Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial

Coronavirus disease 2019 (COVID‐19) is associated with endothelial dysfunction. Pharmacologically targeting the different mechanisms of endothelial dysfunction may improve clinical outcomes and lead to reduced morbidity and mortality. In this pilot, double‐blind, placebo‐controlled, randomized clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Matli, Kamal, Al Kotob, Abdulrahman, Jamaleddine, Wassim, Al Osta, Soad, Salameh, Pascale, Tabbikha, Rami, Chamoun, Nibal, Moussawi, Ahmad, Saad, Jean‐Michel, Atwi, Gibran, Saad, Tarik Abu, Jamal, Omar, Mokhbat, Jacques, Ghanem, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350313/
https://www.ncbi.nlm.nih.gov/pubmed/35808843
http://dx.doi.org/10.1111/cts.13369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350313/
https://www.ncbi.nlm.nih.gov/pubmed/35808843
http://dx.doi.org/10.1111/cts.13369

Ejemplares similares